These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 24123094

  • 1. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Tormey W, Smith D, Thompson CJ, McKenna MJ, Agha A.
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [Abstract] [Full Text] [Related]

  • 2. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
    Behan LA, Carmody D, Rogers B, Hannon MJ, Davenport C, Tormey W, Smith D, Thompson CJ, Stanton A, Agha A.
    Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
    [Abstract] [Full Text] [Related]

  • 3. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
    Dineen R, Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Keevil BG, Tormey W, Smith D, Thompson CJ, McKenna MJ, Arlt W, Stewart PM, Agha A, Sherlock M.
    BMC Endocr Disord; 2020 Oct 10; 20(1):154. PubMed ID: 33036588
    [Abstract] [Full Text] [Related]

  • 4. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
    Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A.
    Clin Endocrinol (Oxf); 2011 Oct 10; 75(4):505-13. PubMed ID: 21521342
    [Abstract] [Full Text] [Related]

  • 5. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM, Freaney R, Smith TP, McBrinn Y, Murray B, McKenna TJ.
    Clin Endocrinol (Oxf); 2003 Sep 10; 59(3):380-7. PubMed ID: 12919163
    [Abstract] [Full Text] [Related]

  • 6. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtimäki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Sievänen H, Vuori I, Väänänen HK, Halleen JM.
    J Bone Miner Res; 2005 Oct 10; 20(10):1804-12. PubMed ID: 16355501
    [Abstract] [Full Text] [Related]

  • 7. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
    Clin Endocrinol (Oxf); 2004 Jun 10; 60(6):688-93. PubMed ID: 15163331
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR, Wright D, Aye M, Moisey R.
    Clin Endocrinol (Oxf); 2012 Jul 10; 77(1):94-8. PubMed ID: 22151005
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP.
    Clin Endocrinol (Oxf); 1997 Mar 10; 46(3):255-61. PubMed ID: 9156031
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
    Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM.
    Clin Endocrinol (Oxf); 2009 Oct 10; 71(4):477-84. PubMed ID: 19170706
    [Abstract] [Full Text] [Related]

  • 11. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
    Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR.
    Bone; 2009 Dec 10; 45(6):1053-8. PubMed ID: 19679211
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar 10; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 13. Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics.
    Rogers RS, Dawson AW, Wang Z, Thyfault JP, Hinton PS.
    J Appl Physiol (1985); 2011 Nov 10; 111(5):1353-60. PubMed ID: 21868687
    [Abstract] [Full Text] [Related]

  • 14. [Short-term effects of citrate on markers of bone metabolism in Chinese blood donor volunteers].
    Chu XL, Hou JM, Lin H, Lin HK, Zeng J, Chen GL, Chen C, Lin J, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun 10; 18(3):785-9. PubMed ID: 20561451
    [Abstract] [Full Text] [Related]

  • 15. [Correlation of sex hormones and parathyroid hormone with biochemical markers of bone turnover in aged men].
    Xiao HY, Lu YH, Gong YP, Pei Y, Cheng XL, Li N, Fang FS, Tian H, Li CL.
    Zhonghua Nan Ke Xue; 2014 Mar 10; 20(3):257-62. PubMed ID: 24738465
    [Abstract] [Full Text] [Related]

  • 16. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
    Sherlock M, Behan LA, Hannon MJ, Alonso AA, Thompson CJ, Murray RD, Crabtree N, Hughes BA, Arlt W, Agha A, Toogood AA, Stewart PM.
    Eur J Endocrinol; 2015 Nov 10; 173(5):583-93. PubMed ID: 26264718
    [Abstract] [Full Text] [Related]

  • 17. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T, Nakamura H.
    Osteoporos Int; 2016 Feb 10; 27(2):729-35. PubMed ID: 26294294
    [Abstract] [Full Text] [Related]

  • 18. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG.
    J Clin Endocrinol Metab; 2014 Jun 10; 99(6):2269-76. PubMed ID: 24606100
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.
    Dunne FP, Elliot P, Gammage MD, Stallard T, Ryan T, Sheppard MC, Stewart PM.
    Clin Endocrinol (Oxf); 1995 Nov 10; 43(5):623-9. PubMed ID: 8548948
    [Abstract] [Full Text] [Related]

  • 20. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP.
    Clin Endocrinol (Oxf); 2003 Nov 10; 59(5):613-20. PubMed ID: 14616886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.